GOZZETTI ALESSANDRO

Alessandro
Gozzetti
Professore Associato

Contacts

0577586784 [int.0577586784]

Curriculum Vitae

Teaching activities

Completion accademic year: 2020/2021

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2017/2018

Completion accademic year: 2019/2020

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2016/2017
Course year: 3 First cycle degree (DM 270) BIOMEDICAL LABORATORY TECHNIQUES A.Y. 2017/2018

Completion accademic year: 2018/2019

Course year: 4 Full cicle (6 years) MEDICINE AND SURGERY A.Y. 2015/2016

Research

Ultime pubblicazioni:

  • Caroni, F., Sammartano, V., Pacelli, P., Sicuranza, A., Malchiodi, M., Dragomir, A., et al. (2025). Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. PHARMACEUTICALS, 18(2) [10.3390/ph18020159]. - view more
  • Santi, A., Venanzi, A., Pucciarini, A., Schiavoni, G., Naccari, M., Albi, E., et al. (2025). Targetable Mutations in BRAF V600E-Negative Hairy-Cell Leukemia. THE NEW ENGLAND JOURNAL OF MEDICINE, 392(14), 1451-1452 [10.1056/NEJMc2500911]. - view more
  • Nardi, F., Del Prete, R., Drago, R., Di Rita, A., Vallone, F.E., Ciofini, S., et al. (2025). Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia. LEUKEMIA, 39(1), 122-133 [10.1038/s41375-024-02442-0]. - view more
  • Sportoletti, P., Laurenti, L., Chiarenza, A., Gaidano, G., Albi, E., Mauro, F.R., et al. (2024). Patients' preferences for chronic lymphocytic leukemia treatment: The CHOICE study. HEMATOLOGICAL ONCOLOGY, 42(1), 1-10 [10.1002/hon.3216]. - view more
  • Lopresti, L., Capitani, N., Tatangelo, V., Tangredi, C., Boncompagni, G., Frezzato, F., et al. (2024). p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 12 [10.3389/fcell.2024.1297116]. - view more